Abstract:
Primer layers for adhesion of a pressure sensitive adhesive material to a substrate are provided. The primer layer comprises a crosslinked polymer. In some embodiments, the primer layer has an atomic nitrogen content of greater than 6 wt %, and in some a ratio of atomic weight percent of oxygen to nitrogen of less than 3.0. In some embodiments the crosslinked polymer is the reaction product of an amine-functional base polymer such as a polyethylenimine (PEI) and a crosslinker, which may be a polyaziridine crosslinker. Also provided are two-layer constructions comprising the primer layer and a substrate layer; and tapes, such as flexographic plate mounting tapes, comprising the two-layer construction and a pressure sensitive adhesive layer.
Abstract:
Adhesive articles suitable for use in medical applications include a siloxane-based pressure sensitive adhesive layer, and a breathable conformable backing having a first surface and a second surface. The siloxane-based pressure sensitive adhesive layer is coated on the first surface of the breathable conformable backing, and the second surface of the breathable conformable backing comprises a treated surface. The siloxane-based pressure sensitive adhesive layer can be attached to skin and other adhesive articles can be releasably adhered to the treated surface to form adhesive constructions.
Abstract:
A fluorochemical composition that includes one or more fluorochemical urethane compounds, a method of treating a substrate (e.g., a method for imparting water and oil repellency and antisoiling characteristics to a substrate), and an article having a fluorochemical composition coating thereon
Abstract:
There are provided primer compositions comprising a primer component comprising: a rubber; an amine-functional (meth)acrylic resin; and a plasticizer. There are also provided articles made using these primer compositions.
Abstract:
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Abstract:
Adhesive articles that include a substrate, a silicone polyoxamide-containing primer layer, and a silicone adhesive are disclosed. Methods of making the adhesive articles and the use of a silicone polyoxamide as a primer for improving adhesion between a substrate and a silicone adhesive are also disclosed.
Abstract:
Imidazo ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Abstract:
Imidazo ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Abstract:
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.